|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.60 BDT | -0.76% |
|
+2.35% | - |
| Market Cap | 24.16B 197M 171M 157M 148M 276M 18.85B 281M 1.88B 727M 9.09B 739M 723M 31.59B | P/E Ratio 2024 |
68.2x | P/E Ratio 2025 | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 34.13B 278M 241M 222M 208M 389M 26.62B 397M 2.65B 1.03B 12.83B 1.04B 1.02B 44.62B | EV / Sales 2024 |
4.25x | EV / Sales 2025 | 2.74x |
| Free-Float |
36.94% | Yield 2024 |
1.3% | Yield 2025 | 1.98% |
| 1 day | -0.76% | ||
| 1 week | +2.35% | ||
| Current month | +2.85% | ||
| 1 month | +2.15% | ||
| 3 months | +2.65% | ||
| 6 months | -2.97% |
| 1 week | 103 |  | 107.3 |
| 1 month | 100.2 | | 107.3 |
| Current year | 96 | | 115 |
| 1 year | 96 | | 147.5 |
| 3 years | 92.4 | | 288.9 |
| 5 years | 92.4 | | 393 |
| 10 years | 15.8 | | 393 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ulfat Karim
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | - | |
| Director/Board Member | 42 | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | +2.35% | -0.38% | -57.31% | 199M | |
| +2.64% | +2.81% | +43.08% | +159.80% | 1,013B | |
| +0.48% | +5.00% | +54.30% | +49.82% | 574B | |
| +0.75% | +0.18% | +17.67% | +63.61% | 397B | |
| -0.37% | +4.97% | +21.24% | +15.95% | 324B | |
| +0.85% | +0.18% | +24.50% | +14.78% | 280B | |
| +2.10% | +4.92% | +25.30% | +33.80% | 273B | |
| +5.16% | +1.53% | +20.25% | +61.43% | 182B | |
| -0.19% | -0.46% | -45.32% | -48.35% | 194B | |
| +4.79% | -2.70% | +15.00% | +61.43% | 151B | |
| Average | +1.51% | +2.30% | +17.56% | +35.50% | 338.88B | |
| Weighted average by Cap. | +1.60% | +3.99% | +29.40% | +72.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.7B 87.19M 75.66M 69.74M 65.35M 122M 8.35B 125M 832M 322M 4.02B 327M 320M 13.99B | 12.54B 102M 88.68M 81.74M 76.59M 143M 9.78B 146M 975M 378M 4.72B 384M 375M 16.4B |
| Net income | 521M 4.24M 3.68M 3.4M 3.18M 5.94M 406M 6.07M 40.5M 15.68M 196M 15.93M 15.59M 681M | 947M 7.71M 6.69M 6.17M 5.78M 10.8M 738M 11.02M 73.58M 28.49M 356M 28.95M 28.33M 1.24B |
| Net Debt | 10B 81.45M 70.68M 65.15M 61.05M 114M 7.8B 116M 777M 301M 3.76B 306M 299M 13.07B | 9.96B 81.17M 70.44M 64.93M 60.84M 114M 7.77B 116M 775M 300M 3.75B 305M 298M 13.03B |
Employees
4,771
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-10 | 104.60 BDT | -0.76% | 223,429 |
| 26-06-10 | 105.40 BDT | +1.84% | 314,978 |
| 26-06-09 | 103.50 BDT | -0.58% | 263,093 |
| 26-06-08 | 104.10 BDT | -1.33% | 378,022 |
| 26-06-07 | 105.50 BDT | +1.44% | 551,655 |
- Stock Market
- Stocks
- BEACONPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
